Eclipsys Corporation is a provider of advanced integrated clinical, revenue cycle and performance management software, and professional services that help healthcare organizations improve clinical, financial, and operational outcomes. It has developed and licensed software and content that is designed for use in connection with many of the key clinical, financial and operational functions that healthcare organizations require. It also provides professional services related to its software. These services include software implementation and maintenance, outsourcing, remote hosting of its software, as well as third-party healthcare information technology applications, technical and user training and consulting. It markets its software to healthcare providers of many different sizes and specialties, including community hospitals, large multi-entity healthcare systems, academic medical centers and physician practices. In January 2009, the Company acquired Premise Corporation.

Looking at ECLP against similar companies like CERN. ECLP looks like it is poised for growth and growing. See the income statement that I like so much:

http://www.google.com/finance?fstype=ii&q=NASDAQ:ECLP

Also its P/E suggests that it is a much better value right now. P/E of ECLP 5.40 vs P/E of CERN of 18.32. In fact last year ECLP had a net income of 99mm on a revenue of 515mm where CERN had a net income of 188mm on a revenue of 1676mm suggesting that they have better operational margins.

We believe this stock is a play to take advantage of the clear push towards heatlh care modernization. As an IT solutions provider in this space we believe this stock could garner a windfall over the next few years.